Home
Astrazeneca AZN paid Tiber Creek Group $80K for lobbying in Q1 2026 · Medicare, Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $80,000
- Quarter
- Q1 2026
- Stock
- Astrazeneca AZN
- Client
- Astrazeneca
- Reported
- 26/04/18
Down 11.1% from last quarter
What else happened in Astrazeneca around then
Filed or reported within 30 days of the trade day · 03/01~04/30Astrazeneca's other lobbying reports
- Astrazeneca
LobbyingAstrazeneca
LobbyingAstrazeneca
AZN
$80K
$80K
Reported 07/19
for Q2
- Astrazeneca
LobbyingAstrazeneca
LobbyingAstrazeneca
AZN
$80K
$80K
Reported 07/16
for Q2
- Astrazeneca
LobbyingAstrazeneca
LobbyingAstrazeneca
AZN
$80K
$80K
Reported 04/20
for Q1
- Astrazeneca
LobbyingAstrazeneca
LobbyingAstrazeneca
AZN
$80K
$80K
Reported 01/20
for Q4 2025
- Astrazeneca
LobbyingAstrazeneca
LobbyingAstrazeneca
AZN
$90K
$90K
Reported 01/20
for Q4 2025